They found that CD5 expression in NMZL correlated with a higher frequency of dissemination as compared to CD5-negative NMZL (n = 66), but patients had an indolent clinical course and excellent overall survival similar to CD5-negative cases [3]. The gene discussed is CD5; the disease is nodal marginal zone B-cell lymphoma.